{"id":15708,"date":"2025-02-28T05:46:52","date_gmt":"2025-02-28T05:46:52","guid":{"rendered":"https:\/\/gsrra.com\/?p=15708"},"modified":"2025-02-28T05:46:55","modified_gmt":"2025-02-28T05:46:55","slug":"pakistans-citi-pharma-completes-first-ever-export-to-mena","status":"publish","type":"post","link":"https:\/\/gsrra.com\/?p=15708","title":{"rendered":"Pakistan\u2019s Citi Pharma completes first-ever export to MENA"},"content":{"rendered":"\n

In a key development for Pakistan\u2019s pharmaceutical sector, Citi Pharma Limited (CPHL) announced on Thursday that it had completed its first-ever export to the MENA region worth EUR 560,000.<\/strong><\/p>\n\n\n\n

\u201cThis export order was received on the basis of the FDA accreditation that Citi Pharma has obtained (announced on 20th September 2024),\u201d the pharmaceutical shared the development in a notice to the Pakistan Stock Exchange (PSX) today.<\/p>\n\n\n\n

It said that the total export value was EUR 560,000, of which it had previously received an advance payment of EUR 200,000.<\/p>\n\n\n\n

\u201cToday we have received the remaining balance of EUR 360,000, finalizing this initial export transaction.\u201d<\/p>\n\n\n\n

Pakistan\u2019s Citi Pharma, Martin Dow partner with Chinese firm for biotech manufacturing<\/a><\/strong><\/p>\n\n\n\n

It added that overall, CPHL is eyeing a total export value of at least EUR 8,000,000 to EUR 10,000,000 annually to the MENA region and a similar amount to other international markets including North America.<\/p>\n\n\n\n

The company stated that the achievement paves the way for Citi Pharma Limited\u2019s growth in international markets, \u201cstrengthening our presence and unlocking new opportunities for the company\u201d.<\/p>\n\n\n\n

\u201cWe remain committed to growth and increasing shareholder value and will keep the shareholders informed,\u201d the CPHL concluded.<\/p>\n\n\n\n

Earlier in February, CPHL decided to venture into the real estate sector with the formation of Citi REIT Management Company<\/a>, its wholly owned subsidiary.<\/p>\n\n\n\n

CPHL\u2019s board also gave its approval for setting up an antibiotic plant for the formulation section.<\/p>\n\n\n\n

Furthermore, the company back then shared that it was also engaging in discussions on the formation of a joint venture with international partners for the development of a hospital.<\/p>\n\n\n\n

Reference Link:- https:\/\/www.brecorder.com\/news\/40350367<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

In a key development for Pakistan\u2019s pharmaceutical sector, Citi Pharma Limited (CPHL) announced on Thursday that it had completed its first-ever export to the MENA region worth EUR 560,000. \u201cThis export order was received on the basis of the FDA accreditation that Citi Pharma has obtained (announced on 20th September 2024),\u201d the pharmaceutical shared the […]<\/p>\n","protected":false},"author":1,"featured_media":15709,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[2],"tags":[7919,132,2267,105,2093,3311,13562,36,13563,13561],"class_list":["post-15708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sample-category","tag-citi-pharma","tag-economy","tag-exports","tag-geopolitics-2","tag-health","tag-medicines","tag-mena","tag-pakistan","tag-pakistans-citi-pharma-completes-first-ever-export-to-mena","tag-pharmaceautical-industry"],"jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/gsrra.com\/index.php?rest_route=\/wp\/v2\/posts\/15708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsrra.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsrra.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsrra.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gsrra.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15708"}],"version-history":[{"count":1,"href":"https:\/\/gsrra.com\/index.php?rest_route=\/wp\/v2\/posts\/15708\/revisions"}],"predecessor-version":[{"id":15710,"href":"https:\/\/gsrra.com\/index.php?rest_route=\/wp\/v2\/posts\/15708\/revisions\/15710"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsrra.com\/index.php?rest_route=\/wp\/v2\/media\/15709"}],"wp:attachment":[{"href":"https:\/\/gsrra.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsrra.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsrra.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}